These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4182)

  • 21. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrinsic sympathomimetic activity and coronary blood flow.
    Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1982; 13(Suppl 2):175S-180S. PubMed ID: 6125167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intrinsic sympathomimetic activity of beta-blockers].
    Waite R
    Nouv Presse Med; 1978 Sep; 7(31):2707-9. PubMed ID: 30947
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
    Ozawa H; Matsubara T; Chen CS
    Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
    Day MD; Roach AG
    Clin Sci Mol Med Suppl; 1975 Jun; 2():269s-272s. PubMed ID: 28878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.
    Giudicelli JF; Lhoste F
    Br J Clin Pharmacol; 1982; 13(Suppl 2):167S-174S. PubMed ID: 6125166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs.
    Wale JL; Austin M; Conway J; Reeves M
    Clin Exp Pharmacol Physiol; 1979; 6(1):11-9. PubMed ID: 32981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
    Zaagsma J; Meems L; Boorsma M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):29-36. PubMed ID: 18685
    [No Abstract]   [Full Text] [Related]  

  • 35. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The properties of beta-adrenoceptor antagonists.
    Shanks RG
    Postgrad Med J; 1976; 52 Suppl 4():14-20. PubMed ID: 9628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN; Brownlee WC; Large DM
    Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats.
    Davy M; Midol-Monnet M; Heimburger M; Wepierre J; Cohen Y
    J Pharmacol; 1986; 17(1):28-36. PubMed ID: 2872366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
    Giudicelli JF; Berdeaux A
    Nouv Presse Med; 1978 Sep; 7(31):2721-5. PubMed ID: 30950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.